Edesa Biotech Inc. logo

Edesa Biotech Inc.

EDSA | NASDAQ
Chart Builder DCF Calculator
$4.11
-$0.03 (-0.72%)
At close: Sep 21, 2026, 4:00 PM ET
$4.11
$0 (0.00%)
After-hours: Sep 21, 2026, 7:48 PM ET

Market Data

Market Cap
$39.88M
Enterprise Value
$29.26M
Beta
1.06
Average Volume
214.97K
Shares Outstanding (Diluted)
9.01M
Shares Change YoY
28.26%
Institutional Ownership
30.95%
Exchange
NASDAQ
ISIN
CA27966L3065

Price Performance

Price Change 1M
-7.6%
Price Change 3M
-46.2%
Price Change 6M
-37.4%
Price Change YTD
174.0%
Price Change 1Y
67.8%
Price Change 3Y
-30.9%
Price Change 5Y
-92.8%
1M CAGR (ann.)
-18.0%
1Y CAGR (ann.)
73.2%
5Y CAGR (ann.)
-36.9%
All-Time CAGR
-26.3%

Valuation

PE Ratio
-2.42
Forward PE
N/A
PEG Ratio
0.08
Forward PEG
-0.61
PS Ratio
N/A
Forward PS
2.10
PB Ratio
3.11
P/FCF Ratio
-4.42
P/Adj. FCF Ratio
-4.23
P/OCF Ratio
-4.15
EV/Sales
N/A
EV/EBIT
-3.30
EV/EBITDA
-2.05
EV/FCF
-3.27
Earnings Yield
-41.4%
FCF Yield
-22.6%
Adj. FCF Yield
-23.6%

Financial Health

Net Cash
$10.33M
Total Debt
$0
Cash & Short-Term Investments
$10.33M
Total Assets
$12.72M
Current Ratio
2.76
Quick Ratio
2.76
Debt / Equity Ratio
0.00
Debt / EBITDA
-0.00
Debt / FCF
-0.00
OCF / Debt
N/A
Interest Coverage
0.00
Altman Z-Score
-4.10
Piotroski F-Score
1

Margins & Profitability

Gross Profit Margin
0.0%
Operating Profit Margin
0.0%
EBITDA Margin
0.0%
Net Profit Margin
0.0%
FCF Margin
N/A
Adj. FCF Margin
N/A
SBC / Revenue
0.0%
SBC Impact (per share)
-4.5%

Returns

Return on Assets
-110.8%
Return on Equity
-124.2%
Return on Invested Capital
-166.0%
Return on Capital Employed
-166.0%
Return on Tangible Assets
-130.3%

Historical Growth (CAGR)

Revenue CAGR 3Y
150.0%
Revenue CAGR 5Y
84.1%
Revenue CAGR 10Y
-47.4%
EPS CAGR 3Y
14.6%
EPS CAGR 5Y
47.8%
EPS CAGR 10Y
41.0%
FCF CAGR 3Y
-25.3%
FCF CAGR 5Y
0.1%
FCF CAGR 10Y
-4.3%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
1
EPS Growth Next 3Y
-13.4%
Revenue Growth Next 3Y
N/A
Earnings Date
Dec 10, 2026
EPS Estimate (next Q)
-$0.58
EPS Growth Est (next Q)
82.3%
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$5
Price Target Upside
21.7%

Cash Flow

Operating Cash Flow
$-8.95M
Free Cash Flow
$-8.95M
Adj. Free Cash Flow
$-9.36M
FCF Per Share
-$0.99
OCF Per Share
-$0.99
OCF/S Ratio
0.0%

Income Statement

Revenue
$0
Gross Profit
$-77.2K
Operating Income
$-14.63M
EBITDA
$-14.3M
Net Income
$-14.1M
EPS (Diluted)
-$1.70
Revenue / Employee
N/A
Profit / Employee
$-829.53K
Employees
17

© 2026 bestshares.com. All rights reserved.